NEU 3.16% $13.18 neuren pharmaceuticals limited

$8.6bn target market..., page-21

  1. 778 Posts.
    Pete

    Good luck with your strategy but bio's are not for the faint hearted and not for anyone who does not understand basis of FDA approval, trials, big pharma key drivers etc. It can be learnt but geez, go and look at PRR thread for some sad stories of big capital losses.

    Unless you have balls of steel and prepared to lase everything- maybe stick to oil and gas.


    Sorry to be so blunt.

    Ramses
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.